A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

Source:http://linkedlifedata.com/resource/pubmed/id/7683702

Download in:

View as

General Info

PMID
7683702